Literature DB >> 9378923

Diagnosis and treatment of uncomplicated urinary tract infection.

T M Hooton1, W E Stamm.   

Abstract

Acute uncomplicated urinary tract infection is one of the most common problems for which young women seek medical attention and accounts for considerable morbidity and health care costs. Acute cystitis or pyelonephritis in the adult patient should be considered uncomplicated if the patient is not pregnant or elderly, if there has been no recent instrumentation or antimicrobial treatment, and if there are no known functional or anatomic abnormalities of the genitourinary tract. Most of these infections are caused by E. coli, which are susceptible to many oral antimicrobials, although resistance is increasing to some of the commonly used agents. Review of the published data suggests that a 3-day regimen is more effective than a single-dose regimen for all antimicrobials tested. Regimens with trimethoprim-sulfamethoxazole seem to be more effective than those with beta lactams, regardless of the duration. Because of increasing resistance to trimethoprim-sulfamethoxazole, an alternative regimen such as nitrofurantoin (in a 7-day regimen), a fluoroquinolone, or an oral third-generation cephalosporin may be a better empiric choice in some areas. Acute pyelonephritis caused by highly virulent uropathogens in an otherwise healthy woman may be considered an uncomplicated infection. The optimal treatment duration for acute uncomplicated pyelonephritis has not been established, but 10- to 14-day regimens are recommended. We prefer to use antimicrobials that attain high renal tissue levels, such as a fluoroquinolone, trimethoprim-sulfamethoxazole, or an aminoglycoside, for pyelonephritis. Acute uncomplicated cystitis or pyelonephritis in healthy adult men is uncommon but is generally caused by the same spectrum of uropathogens with the same antimicrobial susceptibility profile as that seen in women.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378923     DOI: 10.1016/s0891-5520(05)70373-1

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  154 in total

1.  Management of uncomplicated urinary tract infections.

Authors:  Timothy Jancel; Vicky Dudas
Journal:  West J Med       Date:  2002-01

Review 2.  The quinolones and renal infection.

Authors:  A Ronald
Journal:  Drugs       Date:  1999       Impact factor: 9.546

3.  Antibiotic Selection for Urinary Tract Infection: New Microbiologic Considerations.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

4.  Pharmacologic Basis for the Treatment of Pyelonephritis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 5.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

6.  Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Authors:  Laura Ferreira; Fernando Sánchez-Juanes; Magdalena González-Avila; David Cembrero-Fuciños; Ana Herrero-Hernández; José Manuel González-Buitrago; Juan Luis Muñoz-Bellido
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

7.  Symptomatic urinary tract infections after surgery for prolapse and/or incontinence.

Authors:  Gary Sutkin; Marianna Alperin; Leslie Meyn; Harold C Wiesenfeld; Rennique Ellison; Halina M Zyczynski
Journal:  Int Urogynecol J       Date:  2010-03-31       Impact factor: 2.894

8.  Use of time-trend analysis in the design of empirical antimicrobial treatment of urinary tract infection.

Authors:  D Raveh; B Rudensky; M Huerta; Y Aviv; A M Yinnon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-01       Impact factor: 3.267

9.  Urinary tract infection in women--physician's preferences for treatment and adherence to guidelines: a national drug utilization study in a managed care setting.

Authors:  Ernesto Kahan; Natan R Kahan; David P Chinitz
Journal:  Eur J Clin Pharmacol       Date:  2003-09-27       Impact factor: 2.953

10.  Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.

Authors:  James A Karlowsky; Laurie J Kelly; Clyde Thornsberry; Mark E Jones; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.